Aluminum hydroxide Alternatives Compared
Aluminum hydroxide | Omeprazole | Famotidine |
|
---|
Aluminum hydroxide | Omeprazole | Famotidine |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription and OTC
Prescribed for GERD, Erosive Esophagitis, Duodenal Ulcer, Gastrointestinal Hemorrhage, Hyperphosphatemia, Indigestion, Peptic Ulcer, Stomach Ulcer, Zollinger-Ellison Syndrome. Aluminum hydroxide may... View more |
Prescription and OTC
Omeprazole decreases stomach acid production which promotes the healing of gastric and duodenal ulcers and other inflamed areas of gastrointestinal tissue. The risk of interactions with omeprazole... View more |
Prescription and OTC
Famotidine is an acid-suppressing agent that may be used to treat a wide range of gastric-acid-related disorders including gastric ulcers, heartburn, and GERD. A headache is the most common side... View more |
Related suggestions Stomach Ulcer
Indigestion
Erosive Esophagitis
|
|||||||||||||||||||||||
More about Aluminum hydroxide | More about Omeprazole | More about Famotidine | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Be the first to share your experience with this drug. |
Omeprazole has an average rating of 4.6 out of 10 from a total of 491 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 53% reported a negative effect. |
Famotidine has an average rating of 4.4 out of 10 from a total of 170 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 57% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Aluminum hydroxide prices |
View all Omeprazole prices |
View all Famotidine prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Aloh-Gel, Alternagel, Alu-Cap, Alu-Tab, Amphojel, Dialume | Omesec, Prilosec, Prilosec OTC | Acid Control, Acid Controller Maximum Strength, Acid Controller Original Strength, Acid Reducer Maximum Strength, Acid Reducer Original Strength, Acid Reducer-Famotidine, Heartburn Relief, Heartburn Relief Maximum Strength, Pepcid, Pepcid AC, Pepcid AC Chewable Tablets, Pepcid AC Maximum Strength, Pepcid AC Maximum Strength Tablets, Pepcid Oral Suspension, Zantac 360 View more | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
1.5 hours |
4 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 237 drugs are known to interact with Aluminum hydroxide:
|
A total of 225 drugs are known to interact with Omeprazole:
|
A total of 301 drugs are known to interact with Famotidine:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
June 20, 2003 |
October 15, 1986 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.